JP2024526952A5 - - Google Patents
Info
- Publication number
- JP2024526952A5 JP2024526952A5 JP2024503927A JP2024503927A JP2024526952A5 JP 2024526952 A5 JP2024526952 A5 JP 2024526952A5 JP 2024503927 A JP2024503927 A JP 2024503927A JP 2024503927 A JP2024503927 A JP 2024503927A JP 2024526952 A5 JP2024526952 A5 JP 2024526952A5
- Authority
- JP
- Japan
- Prior art keywords
- piperidine
- oxoindolin
- phenylbutan
- oxo
- dimethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163227692P | 2021-07-30 | 2021-07-30 | |
| US63/227,692 | 2021-07-30 | ||
| PCT/JP2022/029430 WO2023008585A1 (en) | 2021-07-30 | 2022-08-01 | Crystalline forms |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024526952A JP2024526952A (ja) | 2024-07-19 |
| JP2024526952A5 true JP2024526952A5 (enExample) | 2025-08-06 |
| JP7765130B2 JP7765130B2 (ja) | 2025-11-06 |
Family
ID=85087024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024503927A Active JP7765130B2 (ja) | 2021-07-30 | 2022-08-01 | 結晶形 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12552776B2 (enExample) |
| EP (1) | EP4377309B1 (enExample) |
| JP (1) | JP7765130B2 (enExample) |
| KR (1) | KR20240042400A (enExample) |
| CN (1) | CN117616022A (enExample) |
| BR (1) | BR112023025271A2 (enExample) |
| CA (1) | CA3223173A1 (enExample) |
| ES (1) | ES3072067T3 (enExample) |
| MX (1) | MX2024000903A (enExample) |
| TW (1) | TW202321216A (enExample) |
| WO (1) | WO2023008585A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12605394B2 (en) | 2024-07-25 | 2026-04-21 | Visionary Assets, Llc | Compositions containing cannabinoid nanoparticles |
| US12667578B2 (en) | 2024-07-25 | 2026-06-30 | Visionary Assets, Llc | Cryogenic process for making cannabinoid nanoparticles and compositions made thereby |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2006221699A1 (en) | 2005-03-11 | 2006-09-14 | Pfizer Inc. | Crystal forms of an imidazole derivative |
| JP5663743B2 (ja) | 2009-02-27 | 2015-02-04 | ラクオリア創薬株式会社 | モチリン受容体作動活性を有するオキシインドール誘導体 |
| CN103702995B (zh) | 2011-05-18 | 2016-04-13 | 拉夸里亚创药株式会社 | 4-{[4-({[4-(2,2,2-三氟乙氧基)-1,2-苯并异噁唑-3-基]氧}甲基)哌啶-1-基]甲基}-四氢-2h-吡喃-4-羧酸的多晶型形式 |
| UY34094A (es) | 2011-05-27 | 2013-01-03 | Novartis Ag | Derivados de la piperidina 3-espirocíclica como agonistas de receptores de la ghrelina |
| WO2013164790A1 (en) | 2012-05-03 | 2013-11-07 | Novartis Ag | L-malate salt of 2, 7 - diaza - spiro [4.5 ] dec- 7 - yle derivatives and crystalline forms thereof as ghrelin receptor agonists |
| JP6572414B2 (ja) | 2014-05-20 | 2019-09-11 | ラクオリア創薬株式会社 | ベンズイソオキサゾール誘導体塩 |
-
2022
- 2022-08-01 CA CA3223173A patent/CA3223173A1/en active Pending
- 2022-08-01 MX MX2024000903A patent/MX2024000903A/es unknown
- 2022-08-01 WO PCT/JP2022/029430 patent/WO2023008585A1/en not_active Ceased
- 2022-08-01 EP EP22849645.1A patent/EP4377309B1/en active Active
- 2022-08-01 JP JP2024503927A patent/JP7765130B2/ja active Active
- 2022-08-01 ES ES22849645T patent/ES3072067T3/es active Active
- 2022-08-01 US US18/291,712 patent/US12552776B2/en active Active
- 2022-08-01 CN CN202280048877.0A patent/CN117616022A/zh active Pending
- 2022-08-01 TW TW111128732A patent/TW202321216A/zh unknown
- 2022-08-01 BR BR112023025271A patent/BR112023025271A2/pt unknown
- 2022-08-01 KR KR1020247000169A patent/KR20240042400A/ko active Pending
-
2026
- 2026-01-14 US US19/448,506 patent/US20260146036A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2023203627A1 (en) | A 7H-pyrrolo[2,3-d]pyrimidine JAK-inhibitor | |
| JP2009514798A5 (enExample) | ||
| JP2007502783A5 (enExample) | ||
| CN113735834B (zh) | 普那布林组合物 | |
| IL311444A (en) | Solid forms, pharmaceutical preparations and preparation of macrocyclic heteroaromatic ether compounds | |
| JP2025512920A5 (enExample) | ||
| WO2018007927A1 (en) | Process for preparation of palbociclib | |
| KR19990023433A (ko) | 결정 형태의 ｎ-(4-트리플루오로메틸페닐)-5-메틸이소옥사졸-4-카복스아미드 | |
| JP2002543076A (ja) | チアゾリジンジオン誘導体および抗糖尿病薬としてのその使用 | |
| EP1485393B1 (en) | 9-dexo-9a-aza-9a-methyl-9a-homoerythromycin a derivatives | |
| CN118804748A (zh) | 固态形式的fgfr抑制剂 | |
| WO2015176591A1 (zh) | 贝曲西班盐及其制备方法和用途 | |
| AU748177B2 (en) | Crystalline forms of osanetant | |
| CN117263913A (zh) | 杂芳基化合物、固体形式、制备方法及其用途 | |
| CN115947734A (zh) | 瑞卢戈利溶剂化物的晶型及其制备方法 | |
| JP2021525275A5 (enExample) | ||
| WO2016127876A1 (zh) | 一种丙酸阿比特龙的晶型及其制备方法 | |
| CN112119073A (zh) | 阿贝西尼的固态形式、其用途和制备 | |
| RU2024104759A (ru) | Кристаллические формы | |
| WO2013013595A1 (zh) | 一种17α-乙酰氧基-11β-(4-N,N-二甲氨基苯基)-19-去甲孕甾-4,9-二烯-3,20-二酮的结晶物及其制备方法 | |
| CN115536654A (zh) | 小檗碱橙皮素盐晶型及其制备方法和其组合物与应用 | |
| JP2024533420A5 (enExample) | ||
| KR101476508B1 (ko) | (S)-베포타스틴 p-톨루엔술폰산염의 신규 결정형 및 이의 제조방법 | |
| CN107954947A (zh) | 沃替西汀氢溴酸盐晶型c及其制备方法 | |
| CN102093387B (zh) | 4,5,6,7-四氢异噁唑并[5,4-c]吡啶-3-醇一水合物的晶型化合物 |